Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32N2O5 |
| Molecular Weight | 368.4678 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O)C(=O)OCC
InChI
InChIKey=IPVQLZZIHOAWMC-QRJUGERDSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14-,15-,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(3AR)-3A-epi-Perindopril is an epimer (S, RS, SS) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This epimer possesses equal activity with the parent compound, perindopril.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
58153637
Created by
admin on Mon Mar 31 22:07:53 GMT 2025 , Edited by admin on Mon Mar 31 22:07:53 GMT 2025
|
PRIMARY | |||
|
E77W873JI7
Created by
admin on Mon Mar 31 22:07:53 GMT 2025 , Edited by admin on Mon Mar 31 22:07:53 GMT 2025
|
PRIMARY | |||
|
145513-31-1
Created by
admin on Mon Mar 31 22:07:53 GMT 2025 , Edited by admin on Mon Mar 31 22:07:53 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD